Who owns Ginkgo Bioworks Holdings, Inc. (DNA)? Elite investor 13F holders

3 tracked elite investors reported holding Ginkgo Bioworks Holdings, Inc as of 2026-06-30, including Viking Global Investors, Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability,…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Viking Global InvestorsGINKGO BIOWORKS HOLDINGS INCSHARE2026-06-302026-08-14 00:00:0035449338.00 USD3577128.000000SharesholdOriginal filing
Renaissance Technologies LLCGINKGO BIOWORKS HOLDINGS INCSHARE2026-06-302026-08-13 00:00:005349973.00 USD539856.000000SharesaddOriginal filing
Tudor InvestmentGINKGO BIOWORKS HOLDINGS INCSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing
D.E. ShawGINKGO BIOWORKS HOLDINGS INCSHARE2026-06-302026-08-14 00:00:001499938.00 USD151356.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown